ABOS
Price
$1.76
Change
-$0.09 (-4.86%)
Updated
Dec 23, 03:52 PM (EDT)
98 days until earnings call
PEPG
Price
$3.88
Change
+$0.25 (+6.89%)
Updated
Dec 23, 04:59 PM (EDT)
87 days until earnings call
Ad is loading...

ABOS vs PEPG

Header iconABOS vs PEPG Comparison
Open Charts ABOS vs PEPGBanner chart's image
Acumen Pharmaceuticals
Price$1.76
Change-$0.09 (-4.86%)
Volume$5.34K
CapitalizationN/A
PepGen
Price$3.88
Change+$0.25 (+6.89%)
Volume$561
CapitalizationN/A
ABOS vs PEPG Comparison Chart
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PEPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. PEPG commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and PEPG is a Hold.

COMPARISON
Comparison
Dec 24, 2024
Stock price -- (ABOS: $1.85 vs. PEPG: $3.63)
Brand notoriety: ABOS and PEPG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 361% vs. PEPG: 602%
Market capitalization -- ABOS: $110.55M vs. PEPG: $118.32M
ABOS [@Biotechnology] is valued at $110.55M. PEPG’s [@Biotechnology] market capitalization is $118.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whilePEPG’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • PEPG’s FA Score: 1 green, 4 red.
According to our system of comparison, PEPG is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 4 TA indicator(s) are bullish while PEPG’s TA Score has 3 bullish TA indicator(s).

  • ABOS’s TA Score: 4 bullish, 4 bearish.
  • PEPG’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ABOS is a better buy in the short-term than PEPG.

Price Growth

ABOS (@Biotechnology) experienced а -8.87% price change this week, while PEPG (@Biotechnology) price change was -22.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.15%. For the same industry, the average monthly price growth was -2.89%, and the average quarterly price growth was +3.31%.

Reported Earning Dates

ABOS is expected to report earnings on Mar 31, 2025.

PEPG is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-2.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PEPG($118M) has a higher market cap than ABOS($111M). PEPG YTD gains are higher at: -46.618 vs. ABOS (-51.823). ABOS has higher annual earnings (EBITDA): -77.89M vs. PEPG (-90.04M). ABOS has more cash in the bank: 200M vs. PEPG (139M). PEPG has less debt than ABOS: PEPG (19M) vs ABOS (28.5M). ABOS (0) and PEPG (0) have equivalent revenues.
ABOSPEPGABOS / PEPG
Capitalization111M118M94%
EBITDA-77.89M-90.04M87%
Gain YTD-51.823-46.618111%
P/E RatioN/AN/A-
Revenue00-
Total Cash200M139M144%
Total Debt28.5M19M150%
TECHNICAL ANALYSIS
Technical Analysis
ABOSPEPG
RSI
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 21 days ago
87%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
82%
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
87%
View a ticker or compare two or three
Ad is loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PEPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OCGSF0.140.01
+6.90%
Outcrop Gold & Silver Corp.
CLPBY11.090.21
+1.93%
Coloplast AS
CHEOY90.560.33
+0.37%
CochLear Ltd.
SAFRY54.730.17
+0.31%
Safran SA
ATHOF3.38-0.03
-0.88%
Athabasca Oil Corp.

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with INZY. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
+2.78%
INZY - ABOS
50%
Loosely correlated
+6.41%
MGTX - ABOS
50%
Loosely correlated
+5.31%
BEAM - ABOS
48%
Loosely correlated
+8.04%
SNDX - ABOS
48%
Loosely correlated
+1.79%
AURA - ABOS
48%
Loosely correlated
+1.11%
More

PEPG and

Correlation & Price change

A.I.dvisor indicates that over the last year, PEPG has been loosely correlated with PRTA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if PEPG jumps, then PRTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEPG
1D Price
Change %
PEPG100%
-11.25%
PRTA - PEPG
53%
Loosely correlated
-4.93%
ABOS - PEPG
37%
Loosely correlated
+2.78%
IMUX - PEPG
29%
Poorly correlated
-3.85%
DNLI - PEPG
29%
Poorly correlated
-0.19%
FGEN - PEPG
29%
Poorly correlated
+13.09%
More